Therefore, the BNP level has a significant correlation with the diameter and persistence of PDA, which can reflect the severity and prognosis of neonates with PDA, and facilitates treatment selection for neonates with PDA. This evidence concerns the gene NPPB and Patent ductus arteriosus.